 Reasons lack benefit immediate angioplasty recombinant tissue plasminogen activator therapy acute myocardial infarction regional wall motion analysis European Cooperative Study Group Regional ventricular wall motion analysis utilizing different methods predischarge ventriculograms patients randomized trial single chain recombinant tissue-type plasminogen activator rt-PA aspirin heparin immediate angioplasty patients acute myocardial infarction univariate analysis difference regional wall motion variables treatment groups individual baseline risk assessment multivariate linear regression analysis baseline characteristics ventricular function thrombolytic therapy outcome coronary angioplasty excess high risk patients invasive treatment group unequal distribution baseline risk linear regression analysis benefit immediate coronary angioplasty adjustment Reocclusion reinfarction invasive noninvasive treatment group patients patent infarct-related vessel angiography days reinfarction angiography trend benefit invasive strategy reocclusion reinfarction responsible lack benefit invasive strategy immediate coronary angioplasty beneficial selected patients complications